Seretide inhalation combined with compound xueshuantong capsule on thrombosis in the elderly patients with COPD in stable

Dan-feng WANG,Lan WANG,Xiao-dong WU
DOI: https://doi.org/10.3969/j.issn.1003-9198.2016.08.011
2016-01-01
Abstract:Objective To explore the effect of seretide inhalation combined with compound xueshuantong capsule on thrombosis in the elderly patients with stable chronic obstructive pulmonary disease ( COPD) . Methods Eighty elderly patients with stable COPD from December 2014 to February 2011 were enrolled in this study and randomly divided into study group and control group, with 40 cases in each group. The control group was treated with seretide inhaler, with dose of 50 μg/500 μg, two times a day. The study group received compound blood stasis capsule additionally on the basis of control group, 3 times a day, each time 1. 2 g, for 1 month. The levels of blood fibrinogen ( FIB) , D?Dimer ( D?D) , to?tal homocysteine ( THCY) , and blood gas index before and after the treatment in two groups were detected and compared. Results The levels of FIB, THCY, D?D, and PaCO2 were decreased, and the level of PaO2 was increased ( P<0. 05) in two groups,especially in the study group(P<0. 05). Conclusions Using seretide inhalation combined with compound xueshuantong capsule plays a stabilizing role in improving prethrombotic state in elderly COPD patients in stable stage, and can effectively improve hypoxia and carbon dioxide retention.
What problem does this paper attempt to address?